Crocker Gary L's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Feb 18, 2022
- Accession no.
- 0000899243-22-007005
- Filed
- Feb 18, 2022
- Trade date
- Feb 16-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $79.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crocker Gary LCIK 0001094201 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2022 | Common Stock | PPurchaseAcquired | +7,945 | $6.20 | +$49,259 | 81,477 | Indirect | |
| Feb 17, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $6.13 | +$30,650 | 86,477 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.